4.6 Article

Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6

Journal

MOVEMENT DISORDERS
Volume 29, Issue 2, Pages 252-255

Publisher

WILEY-BLACKWELL
DOI: 10.1002/mds.25706

Keywords

gait; presymptomatic; ataxia; SCA6; symptomatic

Funding

  1. National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre and Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University
  2. Newcastle upon Tyne Hospitals NHS Foundation Trust
  3. NIHR
  4. MRC [MR/K000608/1] Funding Source: UKRI
  5. Medical Research Council [MR/K000608/1] Funding Source: researchfish
  6. National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish

Ask authors/readers for more resources

Background Spinocerebellar ataxia type 6 (SCA6) is an inherited ataxia with no established treatment. Gait ataxia is a prominent feature causing substantial disability. Understanding the evolution of the gait disturbance is a key step in developing treatment strategies. Methods We studied 9 gait variables in 24 SCA6 (6 presymptomatic; 18 symptomatic) and 24 controls and correlated gait with clinical severity (presymptomatic and symptomatic). Results Discrete gait characteristics precede symptoms in SCA6 with significantly increased variability of step width and step time, whereas a more global gait deficit was evident in symptomatic individuals. Gait characteristics discriminated between presymptomatic and symptomatic individuals and were selectively associated with disease severity. Conclusions This is the largest study to include a detailed characterization of gait in SCA6, including presymptomatic subjects, allowing changes across the disease spectrum to be compared. Selective gait disturbance is already present in SCA6 before clinical symptoms appear and gait characteristics are also sensitive to disease progression. Early gait disturbance likely reflects primary pathology distinct from secondary changes. These findings open the opportunity for early evaluation and sensitive measures of therapeutic efficacy using instrumented gait analysis which may have broader relevance for all degenerative ataxias. (c) 2013 International Parkinson and Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available